The 1a-hydroxylated forms of vitamin D, 1,25-dihydroxycholecalciferol or calcitriol, and 1a-hydroxycholecalciferol
or alfacalcidol, have been proposed as possible therapies for osteoporosis. Both compounds strongly stimulate the intestinal calcium absorption, and the response is dose-dependent.